Lipase Reagent Market Size & Share, by Type (Turbidity Method, Colorimetric Method); Application (Hospitals, Clinics); Indication (Pancreatic Disorders, Cancer, Cystic Fibrosis) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4247
  • Published Date: Feb 23, 2023
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2023-2035

Lipase Reagent Market size is projected to surpass USD 1521 Billion by the end of 2035, growing at a CAGR of 7% during the forecast period i.e., 2023-2035. In the year 2022, the industry size of lipase reagent was over USD 631 Billion.The growth of the market can be attributed to the increasing number of patients who are suffering from different diseases that require lipase analysis. The lipase testing reagents act as indicators to study the presence of pancreas-related disorders and other gastric problems. The rise in widespread demand for lipase testing reagents on account of indigestion, acute and chronic pancreatic disorders, gastroesophageal reflux disease (GERD). and other intestinal disorders is expected to drive the market growth during the forecast period. The incidence of acute pancreatitis raised from 28 per 100,000 population in 1999 to 36 per 100,000 population in 2010.

In addition to these, factors that are believed to fuel the market growth of Lipase Reagent include the increase in diseases like vitamin deficiency, dehydration, malnutrition, high gastric acids, and persistent diarrhea. As per the Centers for Disease Control and Prevention, the number of adults diagnosed with ulcers was about 14.8 million in 2018.

Besides, the demand for lipase testing reagents market is propelling as children with cystic fibrosis (CF) or Schwachman-Diamond Syndrome (SDS) diagnosis increase. Lipase levels are high in patients with cystic fibrosis. According to the World Gastroenterology Organization, out of 100%, 49% of females and 36.6% of males have the most common disorders like constipation, diarrhea, IBS, proctalgia fungal, and dyspepsia at rates of 11.7%, 4.7%, 4.1%, 5.9%, and 7.2% respectively.


Lipase Reagent Market
Get more information on this report: Request Free Sample PDF

Lipase Reagent Sector: Growth Drivers and Challenges

Growth Drivers

  • Increasing Diarrhea Cases in Children- Globally, 1.7 billion children are affected with diarrhea disease every year according to the World Health Organization.
  • Rising Concern for Diagnosis – The accurate detection of several medical disorders that might be suggested by increased levels of lipase in the body is a rising issue. For these kinds of illnesses to be effectively treated and managed, a fast and accurate diagnosis is crucial. The primary diagnosis at office visits for all digestive diseases was stated to be 36.6 million in the year 2010 in the U.S.
  • Government Initiatives in the Healthcare Sector –The Universal Health Coverage progress rate is projected to cover health services to 290 million by 2023, compared to the baseline value of 2018 leaving a difference of 710 million to reach the target.
  • Poor Lifestyle and Nutritional Deficiency – Elevated lipase levels and other metabolic abnormalities can be caused by a poor lifestyle and dietary deficits.  As per the Food and Agriculture Organization of the United Nations, it is estimated that between 720 to 811 million individuals faced hunger worldwide in 2020.
  • Lack of Sanitation Knowledge and the Unhygienic Environment– As of 2021 among 3.6 billion people, only 1.9 billion people are living with basic sanitation services and 494 million go for open defecation. Moreover, the population growth is also leading to higher demand for sanitation services, which is further anticipated to boost the market growth. The world population raised from about 1 billion in 1800 to 7.9 billion in 2019.

Challenges

  • Lack of Proper Healthcare System in Low-Income Regions
  • Less Awareness of the Diagnosis and Gastric Issues
  • High Treatment Cost – When medical disorders that are indicated by higher lipase levels are treated, the costs might be significant, particularly if hospitalization, operation, or long-term medication is necessary. In 2019, one-fourth, about 26% of U.S. adults reported that they had a problem paying medical bills, 2018.

Lipase Reagent Market: Key Insights

Base Year

2022

Forecast Year

2023-2035

CAGR

~7%

Base Year Market Size (2022)

~ USD 631 Billion

Forecast Year Market Size (2035)

~ USD 1521 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Lipase Reagent Segmentation

Application (Hospitals, Clinics)

The global lipase reagent market is segmented and analyzed for demand and supply by application into hospitals, clinics & others, out of which, the hospital segment is anticipated to hold the largest market size by the end of 2035. The market is estimated to grow on account of expanding healthcare sector and advancements in technology within the medical sector for diagnostics and therapeutics. As per estimations of the Organization for Economic Co-operation and Development (OECD), health expenditure raised by 5% from 8.8% GDP in 2019 to 9.7% GDP in 2020 across OECD countries.

Indication (Pancreatic Disorders, Cancer, Cystic Fibrosis)

The global lipase reagent market is also segmented and analyzed for demand and supply by indication into pancreatic disorders, cancer, and cystic fibrosis. Out of these segments, the pancreatic disorders segment is projected to garner the highest market revenue by the end of 2035. The segment is growing on the fact that most cases of high lipase levels indicate a problem with the pancreas. For pancreatic illnesses to be effectively treated and managed, an accurate and fast diagnosis is essential, and measuring lipase levels can be a key step in this process. For instance, it was found that about 45 to 350 in million people suffer from acute pancreatitis in the U.S.

Our in-depth analysis of the global market includes the following segments:

            By Type

  • Turbidity Method
  • Colorimetric Method

            By Application

  • Hospitals
  • Clinics
  • Others

             By Indication

  • Pancreatic Disorders
  • Cancer
  • Cystic Fibrosis

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Lipase Reagent Industry - Regional Synopsis

North American Market Forecast

The North American lipase reagent is projected to hold the largest market share by the end of 2035, on the back of increasing concern among people about complications related to the gastrointestinal tract. Among 440 million non-cancer medical conditions, over 22 million acute digestive conditions with 11 million gastroenteritis and 6 million indigestion cases are reported. Besides, the North American region is having good infrastructure and more hospitals propelling the growth of the global lipase reagent market during the forecast period. According to the American Hospital Association, the total number of all hospitals in the North American region is 6,000 with staffed beds of 920,000 in 2022. Also, the regional government policies towards public health care programs attribute to the growth of the market.

APAC Market Statistics

Moreover, the Asia Pacific lipase reagent market is also growing at a fast rate, owing to the rising demand for lipase reagents in the pharma, food and beverage, and biotech sectors. The need for lipase reagents for use in developing drugs, biomarker identification, and bioprocessing applications is rising as a result of the rapidly developing biotechnology and pharmaceutical sectors. The requirement for lipase reagents in the detection and treatment of lifestyle-related disorders like diabetes and obesity is rising as their prevalence rises. The need for lipase reagents for use in food evaluation and quality control is also rising as a result of the region's expanding food and beverage industries, notably in nations like China and India.

Research Nester
Lipase Reagent Market Size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Lipase Reagent Landscape

top-features-companies
    • DIALAB
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • DiaSys Diagnostic Systems GmbH
    • Sunson Industry Group Co., Ltd
    • Randox Laboratories Ltd.
    • Abbott, Beckman Coulter, Inc.
    • Biocompare,
    • VitroScient
    • Merck Group
    • Sisco Research Laboratories Pvt. Ltd.
    • BioSystems

In-the-news

In The News

  • AzuR: announced a positive result of MS1819 during phase 2 trials, by assessing MS1819 along with porcine-derived pancreatic enzyme replacement therapy for treating severe exocrine pancreatic insufficiency in patients with cystic fibrosis.

  • DiaSysDiagnostic Systems GmH announced the development of Lipase DC FS, a state-of-the-art direct colorimetric assay, with improved stability for Pancreatic Diagnosis.

 

 

 

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 4247
  • Published Date: Feb 23, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing gastrointestinal issues and rising concern for diagnosis are the major factors driving the growth of the lipase reagent market.

The market is anticipated to attain a CAGR of ~7% over the forecast period, i.e., 2023-2035.

Lack of a proper healthcare system in low-income regions and less awareness of the diagnosis and gastric issues are the challenges affecting the market growth.

The market in North America region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market DIALAB, DiaSys Diagnostic Systems GmbH, Sunson Industry Group Co.,Ltd, Randox Laboratories Ltd., Abbott, Beckman Coulter, Inc., Biocompare, VitroScient, Merck Group, Sisco Research Laboratories Pvt. Ltd. BioSystems.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by type, application, indication, and by region.

The hospitals segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Lipase Reagent Market Report Scope
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying